1206 related articles for article (PubMed ID: 16142050)
1. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Vignau J; Karila L; Costisella O; Canva V
Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
[TBL] [Abstract][Full Text] [Related]
2. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
3. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
Schaefer M; Mauss S
Curr Drug Abuse Rev; 2008 Jun; 1(2):177-87. PubMed ID: 19630716
[TBL] [Abstract][Full Text] [Related]
5. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
Lang JP; Meyer N; Doffoel M
Encephale; 2003; 29(4 Pt 1):362-5. PubMed ID: 14615706
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
Hauser P
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
[TBL] [Abstract][Full Text] [Related]
7. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
[TBL] [Abstract][Full Text] [Related]
8. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
Wichers M; Maes M
Int J Neuropsychopharmacol; 2002 Dec; 5(4):375-88. PubMed ID: 12466036
[TBL] [Abstract][Full Text] [Related]
9. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Verkerk R; Meltzer H; Maes M
J Clin Psychopharmacol; 2002 Feb; 22(1):86-90. PubMed ID: 11799348
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
Neri S; Pulvirenti D; Bertino G
Clin Drug Investig; 2006; 26(11):655-62. PubMed ID: 17163300
[TBL] [Abstract][Full Text] [Related]
11. A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.
Loftis JM; Wall JM; Linardatos E; Benvenga S; Hauser P
J Endocrinol Invest; 2004; 27(7):RC16-20. PubMed ID: 15505982
[TBL] [Abstract][Full Text] [Related]
12. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.
Loftis JM; Patterson AL; Wilhelm CJ; McNett H; Morasco BJ; Huckans M; Morgan T; Saperstein S; Asghar A; Hauser P
J Psychosom Res; 2013 Jan; 74(1):57-63. PubMed ID: 23272989
[TBL] [Abstract][Full Text] [Related]
13. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
14. [Neuropsychiatric symptoms related to interferon alpha].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Kiejna A
Psychiatr Pol; 2006; 40(4):787-97. PubMed ID: 17068950
[TBL] [Abstract][Full Text] [Related]
15. Serotonin gene polymorphisms and lifetime mood disorders in predicting interferon-induced depression in chronic hepatitis C.
Cozzolongo R; Porcelli P; Cariola F; Giannuzzi V; Lanzilotta E; Gentile M; Sonnante G; Leandro G
J Affect Disord; 2015 Sep; 183():90-7. PubMed ID: 26001668
[TBL] [Abstract][Full Text] [Related]
16. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.
Amodio P; De Toni EN; Cavalletto L; Mapelli D; Bernardinello E; Del Piccolo F; Bergamelli C; Costanzo R; Bergamaschi F; Poma SZ; Chemello L; Gatta A; Perini G
J Affect Disord; 2005 Jan; 84(1):93-8. PubMed ID: 15620390
[TBL] [Abstract][Full Text] [Related]
17. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
[TBL] [Abstract][Full Text] [Related]
18. Altered thymic function during interferon therapy in HCV-infected patients.
Beq S; Rozlan S; Pelletier S; Willems B; Bruneau J; Lelievre JD; Levy Y; Shoukry NH; Cheynier R
PLoS One; 2012; 7(4):e34326. PubMed ID: 22529911
[TBL] [Abstract][Full Text] [Related]
19. Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.
Whale R; Fialho R; Rolt M; Eccles J; Pereira M; Keller M; File A; Haq I; Tibble J
J Psychosom Res; 2015 Dec; 79(6):640-5. PubMed ID: 26117091
[TBL] [Abstract][Full Text] [Related]
20. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study.
Reichenberg A; Gorman JM; Dieterich DT
AIDS; 2005 Oct; 19 Suppl 3():S174-8. PubMed ID: 16251815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
